cc-223
Showing 1 - 4 of 4
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Safety and Pharmacokinetics in Healthy Volunteer Subjects Trial in Madison (CC-223)
Completed
- Safety and Pharmacokinetics in Healthy Volunteer Subjects
- CC-223
-
Madison, WisconsinCovance Research Unit, Inc
Nov 7, 2019